Skip to main content
Top
Published in: Neuroradiology 5/2004

01-05-2004 | Diagnostic Neuroradiology

MR imaging and spectroscopy in Lhermitte-Duclos disease

Authors: S. Nagaraja, T. Powell, P. D. Griffiths, I. D. Wilkinson

Published in: Neuroradiology | Issue 5/2004

Login to get access

Abstract

Lhermitte-Duclos disease is a rare abnormality occurring in the cerebellum with only 130 cases reported in the literature. There is debate as to whether this abnormality is a hamartoma, a malformation or a tumour. In this case report we discuss the spectroscopy findings from two patients presenting with this disease. The patients, one 40-year-old Caucasian woman with a 6-year history of headaches, unsteady gait and falls, deterioration in vision and another 28-year-old Caucasian man with a 1-year history of headaches and a previous history of a transient stroke, were found to have this lesion in the cerebellum. Proton spectroscopic data were obtained using a single-voxel PRESS technique (TE=135 ms, TR=1600 ms), from the region of the abnormality. The results were expressed as ratios under the three prominent resonances representing choline (Cho), creatine (Cr), and N-acetyl (NA) moieties. The metabolite ratios were compared to normative data. The two cases demonstrated reduced ratios in NA/Cho and NA/Cr in relation to the controls. The ratios of Cho/Cr appeared closer to the normal mean ratio. There were peaks attributable to lactate in both cases. The low NA/Cr and NA/Cho ratios could be due to the apparent lack of neuronal architecture and the presence of embryonic neural tissue, which does not express NA, indicating more favourably towards a ‘benign’ hamartoma rather than a tumour.
Literature
1.
go back to reference Ashley DG, Zee CS, Chandrasoma PT, Segall HD (1990) Lhermitte-Duclos disease: CT and MR findings. J Comput Assist Tomogr 14:984–987PubMed Ashley DG, Zee CS, Chandrasoma PT, Segall HD (1990) Lhermitte-Duclos disease: CT and MR findings. J Comput Assist Tomogr 14:984–987PubMed
2.
go back to reference Klisch J, Juengling F, Spreer J, Koch D, Thiel T, Buchert M, Arnold S, Feuerhake F, Schumacher M (2001) Lhermitte-Duclos disease: assessment with MR imaging, positron emission tomography, single-photon emission CT, and MR spectroscopy. AJNR Am J Neuroradiol 22:824–830PubMed Klisch J, Juengling F, Spreer J, Koch D, Thiel T, Buchert M, Arnold S, Feuerhake F, Schumacher M (2001) Lhermitte-Duclos disease: assessment with MR imaging, positron emission tomography, single-photon emission CT, and MR spectroscopy. AJNR Am J Neuroradiol 22:824–830PubMed
3.
go back to reference Murray C, Shipman P, Khangure M, Chakera T, Robbins P, McAuliffe W, Davis S (2001) Lhermitte-Duclos disease associated with Cowden’s syndrome: case report and literature review. Australas Radiol 45:343–346CrossRefPubMed Murray C, Shipman P, Khangure M, Chakera T, Robbins P, McAuliffe W, Davis S (2001) Lhermitte-Duclos disease associated with Cowden’s syndrome: case report and literature review. Australas Radiol 45:343–346CrossRefPubMed
4.
go back to reference Nowak DA, Trost HA, Porr A, Stolzle A, Lumenta CB (2001) Lhermitte-Duclos disease (dysplastic gangliocytoma of the cerebellum). Clin Neurol Neurosurg 103:105–110CrossRefPubMed Nowak DA, Trost HA, Porr A, Stolzle A, Lumenta CB (2001) Lhermitte-Duclos disease (dysplastic gangliocytoma of the cerebellum). Clin Neurol Neurosurg 103:105–110CrossRefPubMed
5.
go back to reference Roski RA, Roessmann U, Spetzler RF, Kaufman B, Nulsen FE (1981) Clinical and pathological study of dysplastic gangliocytoma. Case report. J Neurosurg 55:318–321PubMed Roski RA, Roessmann U, Spetzler RF, Kaufman B, Nulsen FE (1981) Clinical and pathological study of dysplastic gangliocytoma. Case report. J Neurosurg 55:318–321PubMed
6.
go back to reference Nowak DA, Trost HA (2002) Lhermitte-Duclos disease (dysplastic cerebellar gangliocytoma): a malformation, hamartoma or neoplasm? Acta Neurol Scand 105:137–145CrossRefPubMed Nowak DA, Trost HA (2002) Lhermitte-Duclos disease (dysplastic cerebellar gangliocytoma): a malformation, hamartoma or neoplasm? Acta Neurol Scand 105:137–145CrossRefPubMed
7.
go back to reference Nelen MR, Padberg GW, Peeters EA, Lin AY, van den Helm B, Frants RR, Coulon V, Goldstein AM, van Reen MM, Easton DF, Eeles RA, Hodgsen S, Mulvihill JJ, Murday VA, Tucker MA, Mariman EC, Starink TM, Ponder BA, Ropers HH, Kremer H, Longy M, Eng C (1996) Localization of the gene for Cowden disease to chromosome 10q22–23. Nat Genet 13:114–116PubMed Nelen MR, Padberg GW, Peeters EA, Lin AY, van den Helm B, Frants RR, Coulon V, Goldstein AM, van Reen MM, Easton DF, Eeles RA, Hodgsen S, Mulvihill JJ, Murday VA, Tucker MA, Mariman EC, Starink TM, Ponder BA, Ropers HH, Kremer H, Longy M, Eng C (1996) Localization of the gene for Cowden disease to chromosome 10q22–23. Nat Genet 13:114–116PubMed
8.
go back to reference Albrecht S, Haber RM, Goodman JC, Duvic M (1992) Cowden syndrome and Lhermitte-Duclos disease. Cancer 70:869–876PubMed Albrecht S, Haber RM, Goodman JC, Duvic M (1992) Cowden syndrome and Lhermitte-Duclos disease. Cancer 70:869–876PubMed
9.
go back to reference Padberg GW, Schot JD, Vielvoye GJ, Bots GT, de Beer FC (1991) Lhermitte-Duclos disease and Cowden disease: a single phakomatosis. Ann Neurol 29:517–523PubMed Padberg GW, Schot JD, Vielvoye GJ, Bots GT, de Beer FC (1991) Lhermitte-Duclos disease and Cowden disease: a single phakomatosis. Ann Neurol 29:517–523PubMed
10.
11.
go back to reference Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C, Parsons R (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16:64–67PubMed Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C, Parsons R (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16:64–67PubMed
12.
go back to reference Sutphen R, Diamond TM, Minton SE, Peacocke M, Tsou HC, Root AW (1999) Severe Lhermitte-Duclos disease with unique germline mutation of PTEN. Am J Med Genet 82:290–293CrossRefPubMed Sutphen R, Diamond TM, Minton SE, Peacocke M, Tsou HC, Root AW (1999) Severe Lhermitte-Duclos disease with unique germline mutation of PTEN. Am J Med Genet 82:290–293CrossRefPubMed
13.
go back to reference Howe FA, Barton SJ, Cudlip SA, Stubbs M, Saunders DE, Murphy M, Wilkins P, Opstad KS, Doyle VL, McLean MA, Bell BA, Griffiths JR (2003) Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 49:223–232CrossRefPubMed Howe FA, Barton SJ, Cudlip SA, Stubbs M, Saunders DE, Murphy M, Wilkins P, Opstad KS, Doyle VL, McLean MA, Bell BA, Griffiths JR (2003) Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 49:223–232CrossRefPubMed
14.
go back to reference Wang Z, Sutton LN, Cnaan A, Haselgrove JC, Rorke LB, Zhao H, Bilaniuk LT, Zimmerman RA (1995) Proton MR spectroscopy of pediatric cerebellar tumors. AJNR Am J Neuroradiol 16:1821–1833PubMed Wang Z, Sutton LN, Cnaan A, Haselgrove JC, Rorke LB, Zhao H, Bilaniuk LT, Zimmerman RA (1995) Proton MR spectroscopy of pediatric cerebellar tumors. AJNR Am J Neuroradiol 16:1821–1833PubMed
15.
go back to reference Wilken B, Helms G, Christen HJ, Behnke J, Frahm J, Hanefeld F (1996) Localized proton magnetic resonance spectroscopy of a cerebellar tumor in a two-year-old child. Childs Nerv Syst 12:626–629PubMed Wilken B, Helms G, Christen HJ, Behnke J, Frahm J, Hanefeld F (1996) Localized proton magnetic resonance spectroscopy of a cerebellar tumor in a two-year-old child. Childs Nerv Syst 12:626–629PubMed
16.
go back to reference Fountas KN, Kapsalaki EZ, Gotsis SD, Kapsalakis JZ, Smisson HF3, Johnston KW, Robinson JS, Jr., Papadakis N (2000) In vivo proton magnetic resonance spectroscopy of brain tumors. Stereotact Funct Neurosurg 74:83–94CrossRefPubMed Fountas KN, Kapsalaki EZ, Gotsis SD, Kapsalakis JZ, Smisson HF3, Johnston KW, Robinson JS, Jr., Papadakis N (2000) In vivo proton magnetic resonance spectroscopy of brain tumors. Stereotact Funct Neurosurg 74:83–94CrossRefPubMed
17.
go back to reference Harting I, Hartmann M, Jost G, Sommer C, Ahmadi R, Heiland S, Sartor K (2003) Differentiating primary central nervous system lymphoma from glioma in humans using localised proton magnetic resonance spectroscopy. Neurosci Lett 342:163–166CrossRefPubMed Harting I, Hartmann M, Jost G, Sommer C, Ahmadi R, Heiland S, Sartor K (2003) Differentiating primary central nervous system lymphoma from glioma in humans using localised proton magnetic resonance spectroscopy. Neurosci Lett 342:163–166CrossRefPubMed
18.
go back to reference Vuori K, Kankaanranta L, Hakkinen AM, Gaily E, Valanne L, Granstrom ML, Joensuu H, Blomstedt G, Paetau A, Lundbom N (2004) Low-grade gliomas and focal cortical developmental malformations: differentiation with proton MR spectroscopy. Radiology 230:703–708PubMed Vuori K, Kankaanranta L, Hakkinen AM, Gaily E, Valanne L, Granstrom ML, Joensuu H, Blomstedt G, Paetau A, Lundbom N (2004) Low-grade gliomas and focal cortical developmental malformations: differentiation with proton MR spectroscopy. Radiology 230:703–708PubMed
Metadata
Title
MR imaging and spectroscopy in Lhermitte-Duclos disease
Authors
S. Nagaraja
T. Powell
P. D. Griffiths
I. D. Wilkinson
Publication date
01-05-2004
Publisher
Springer-Verlag
Published in
Neuroradiology / Issue 5/2004
Print ISSN: 0028-3940
Electronic ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-004-1201-7

Other articles of this Issue 5/2004

Neuroradiology 5/2004 Go to the issue

Announcements

May 2004